Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleSubcutaneous Daratumumab Plus Carfilzomib and Dexamethasone (D-Kd) in Relapsed/Refractory Multiple Myeloma: An Open-label, Multicenter, Phase 2 Study (PLEIADES).AuthorsChari, Ajai; Goldschmidt, Hartmut; yang, shiyi; Kosh, Michele; Delioukina, Maria; Qi, Ming; Moreau, PhilippePublicationClinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pe144ISSN2152-2650Publication typeArticleDOI10.1016/j.clml.2019.09.240